In 2014, it reached 6.5 billion dollars worldwide, compared to 2.9 in 2013.
The digital revolution continues to radically transform healthcare. In 2014, investment in 'virtual' health exceeded $6.5 billion worldwide, up from $2.9 billion a year earlier. More than double, then.
The crucial question for pharmaceutical companies is how to keep up with these changes. To answer, McKinsey & Co. investigated by interviewing 20 opinion leaders in various sectors: analysts, experts in biotech, pharma, data, technology, venture capital and suppliers. And the belief is that the drug industry must change in order to remain competitive.
Successful companies - the report highlights - will be those able to rethink their business and operational models, adopting a new long-term mentality that promotes innovation. In fact, the technology is already available, but pharmaceutical companies still have to change if they intend to exploit it successfully. These themes strongly suggest that success in the new digital context requires some awareness: first, people increasingly control their health thanks to smartphones and the internet, and even doctors will need to change their view, in light of this hired.
Barbara Di Chiara – December 14, 2015 – PharmaKronos
Related news: How pharma can win in a digital world
